{"transactions":[{"id":1758801,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":108942,"kind":"person","name":"ABBOT STEWART","position":1,"cik":"0001655597","reported_name":"ABBOT STEWART","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-10-17T18:35:44.000Z","date":"2023-10-16","kind":"grant","planned":false,"acquired":true,"shares":45542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on October 12, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":45542,"derivative":{"exercise_price":2.61,"expiration_date":"2033-10-15","underlying":"Common Stock","underlying_shares":45542},"source":{"system":"sec-edgar","filing":"0001209191-23-052993","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1655597/000120919123052993/doc4.xml","form_type":"4"}},{"id":2670260,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":108942,"kind":"person","name":"ABBOT STEWART","position":1,"cik":"0001655597","reported_name":"ABBOT STEWART","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Non-Qualified Option (right to buy)","published_at":"2021-06-14T20:28:37.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest in twelve equal monthly installments commencing on June 11, 2021."}],"balance_after":5000,"derivative":{"exercise_price":11.75,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-040232","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919121040232/doc4.xml","form_type":"4"}},{"id":2855018,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":108942,"kind":"person","name":"ABBOT STEWART","position":1,"cik":"0001655597","reported_name":"ABBOT STEWART","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T02:18:06.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":106900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the Vesting Commencement date, provided that the Reporting Person remains in continuous service as of the applicable vesting dates."}],"balance_after":106900,"derivative":{"exercise_price":16.82,"expiration_date":"2031-02-11","underlying":"Common Stock","underlying_shares":106900},"source":{"system":"sec-edgar","filing":"0000899243-21-007032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321007032/doc4.xml","form_type":"4"}},{"id":2906143,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":108942,"kind":"person","name":"ABBOT STEWART","position":1,"cik":"0001655597","reported_name":"ABBOT STEWART","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-15T21:30:09.000Z","date":"2021-01-13","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the Vesting Commencement date, provided that the Reporting Person remains in continuous service as of the applicable vesting dates."}],"balance_after":80000,"derivative":{"exercise_price":13.27,"expiration_date":"2031-01-12","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0000899243-21-002188","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321002188/doc4.xml","form_type":"4"}},{"id":3028656,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":108942,"kind":"person","name":"ABBOT STEWART","position":1,"cik":"0001655597","reported_name":"ABBOT STEWART","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2020-09-18T01:50:36.000Z","date":"2020-09-17","kind":"grant","acquired":true,"shares":63751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares of common stock subject to the option shall vest on each of the forty-eight (48) monthly anniversaries of the vesting commencement date, provided that Dr. Abbot remains in continuous service as of the applicable vesting date."}],"balance_after":63751,"derivative":{"exercise_price":16.11,"expiration_date":"2030-09-17","underlying":"Common Stock","underlying_shares":63751},"source":{"system":"sec-edgar","filing":"0000899243-20-025646","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924320025646/doc4.xml","form_type":"4"}},{"id":3028655,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":108942,"kind":"person","name":"ABBOT STEWART","position":1,"cik":"0001655597","reported_name":"ABBOT STEWART","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-09-18T01:50:36.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":57151,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in exchange for an employee stock option to acquire 460,900 shares of common stock of Old Adicet for $0.740 per share in connection with the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the option vests on each of the forty-eight (48) monthly anniversaries of October 15, 2019, provided that Dr. Abbot remains in continuous service as of the applicable vesting date."}],"balance_after":57151,"derivative":{"exercise_price":5.97,"expiration_date":"2029-10-15","underlying":"Common Stock","underlying_shares":57151},"source":{"system":"sec-edgar","filing":"0000899243-20-025646","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924320025646/doc4.xml","form_type":"4"}},{"id":3028654,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":108942,"kind":"person","name":"ABBOT STEWART","position":1,"cik":"0001655597","reported_name":"ABBOT STEWART","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-09-18T01:50:36.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":84791,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in exchange for an employee stock option to acquire 683,800 shares of common stock of Adicet Bio, Inc., a Delaware corporation (\"Old Adicet\"), for $0.280 per share in connection with the merger (the \"Merger\") of Old Adicet with and into Project Oasis Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of resTORbio, Inc., a Delaware corporation (\"resTORbio\").  On the effective date of the Merger, resTORbio changed its name to \"Adicet Bio, Inc.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option vested on June 27, 2019, and 1/36th of the remaining unvested option vests on each of the next thirty-six (36) monthly anniversaries thereafter, provided that Dr. Abbot remains in continuous service as of the applicable vesting date."}],"balance_after":84791,"derivative":{"exercise_price":2.26,"expiration_date":"2028-08-14","underlying":"Common Stock","underlying_shares":84791},"source":{"system":"sec-edgar","filing":"0000899243-20-025646","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924320025646/doc4.xml","form_type":"4"}},{"id":3930734,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":108942,"kind":"person","name":"ABBOT STEWART","position":1,"cik":"0001655597","reported_name":"ABBOT STEWART","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-05-16T21:28:19.000Z","date":"2018-05-15","kind":"exercise","acquired":false,"shares":18138,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall vest and become exercisable at the rate of 1/4th of the shares on July 13, 2016 and 1/48th of the shares each month thereafter such that this option is fully exercisable on July 13, 2019. This option is subject to an accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer."}],"balance_after":51862,"derivative":{"exercise_price":6.9,"expiration_date":"2025-08-03","underlying":"Common Stock","underlying_shares":18138},"source":{"system":"sec-edgar","filing":"0001209191-18-030617","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919118030617/doc4.xml","form_type":"4"}},{"id":3930733,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":108942,"kind":"person","name":"ABBOT STEWART","position":1,"cik":"0001655597","reported_name":"ABBOT STEWART","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-05-16T21:28:19.000Z","date":"2018-05-15","kind":"exercise","acquired":false,"shares":2916,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on November 12, 2015, such that this option is fully exercisable on October 12, 2019, subject to the recipient's continued service relationship with the Issuer. This option is subject to an accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer."}],"balance_after":67084,"derivative":{"exercise_price":4.89,"expiration_date":"2025-10-15","underlying":"Common Stock","underlying_shares":2916},"source":{"system":"sec-edgar","filing":"0001209191-18-030617","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919118030617/doc4.xml","form_type":"4"}},{"id":3930732,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":108942,"kind":"person","name":"ABBOT STEWART","position":1,"cik":"0001655597","reported_name":"ABBOT STEWART","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-05-16T21:28:19.000Z","date":"2018-05-15","kind":"exercise","acquired":true,"shares":18138,"price":6.9,"value":125152.2,"ownership":{"direct":true},"balance_after":64917,"source":{"system":"sec-edgar","filing":"0001209191-18-030617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919118030617/doc4.xml","form_type":"4"}},{"id":3930731,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":108942,"kind":"person","name":"ABBOT STEWART","position":1,"cik":"0001655597","reported_name":"ABBOT STEWART","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-05-16T21:28:19.000Z","date":"2018-05-15","kind":"exercise","acquired":true,"shares":2916,"price":4.89,"value":14259.24,"ownership":{"direct":true},"balance_after":46779,"source":{"system":"sec-edgar","filing":"0001209191-18-030617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919118030617/doc4.xml","form_type":"4"}},{"id":4097752,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":108942,"kind":"person","name":"ABBOT STEWART","position":1,"cik":"0001655597","reported_name":"ABBOT STEWART","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-17T21:05:12.000Z","date":"2018-01-16","kind":"grant","acquired":true,"shares":186000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 16, 2018 such that this option is fully exercisable on January 16, 2022."}],"balance_after":186000,"derivative":{"exercise_price":6.55,"expiration_date":"2028-01-15","underlying":"Common Stock","underlying_shares":186000},"source":{"system":"sec-edgar","filing":"0001209191-18-003918","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919118003918/doc4.xml","form_type":"4"}},{"id":4496299,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":108942,"kind":"person","name":"ABBOT STEWART","position":1,"cik":"0001655597","reported_name":"ABBOT STEWART","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-06T21:02:09.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 4, 2017 such that this option is fully exercisable on January 4, 2021."}],"balance_after":150000,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-17-002628","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919117002628/doc4.xml","form_type":"4"}}]}